On the other hand, patients with PCa with high LKB1 expression should be candidates for dual kinase inhibition targeting both p38MAPK and AMPK or for a treatment targeting the autophagic apparatus. The gene discussed is PRKAB1; the disease is posterior cortical atrophy.